Antibiotic Resistance Diagnostics Market

Category : Healthcare & Life Sciences Reports | Delivery Format : PDF,PPT | Publisher: Reports and Insights | Pages : 230

To learn more about this report, request a free sample copy

Antibiotic Resistance Diagnostics Market Overview

The report is titled ‘Antibiotic Resistance Diagnostics Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the antibiotic resistance diagnostics market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The antibiotic resistance diagnostics market is expected to grow at a significant rate in the near future.

The global antibiotic resistance diagnostics market is estimated to reach at a value of US$ xx Mn by the end of 2020 and expected to reach at a value of US$ xx Mn by 2028 with a significant CAGR of xx%

Antibiotic Resistance Diagnostics Introduction

Antibiotic resistance composes a global strain and is one of the crucial threats to public health. Even though the advent of resistant microorganisms is a natural occurrence, the unseemly or overuse of antibiotics is likely to have a significant impact on resistance phylogeny. The rapid antibiotic diagnostic tests determine drug-resistant bacteria, identify antimicrobial receptiveness and differ viral from bacterial infections which resultantly channelize effective treatment strategies. Over and above, the antibiotic diagnostic tests can expedite epidemiological vigilance, as nascent resistant infectious agents and transmittal can be kept under surveillance. Moreover, albeit emergency or rapid tests for infection are considered to have a positive impact at the particular patient level, the diagnostics have a comprehensive and complete role in regulating antimicrobial resistance. Diagnostics makes possible the suitable use of new and emerging drugs when they are put forward into clinical practice and all over their commercial life cycle.

Antibiotic Resistance Diagnostics Market Dynamics

The antimicrobial resistance diagnostics market is anticipated to slow growth during the forecast period, owing to the growing occurrence of infectious diseases coupled with the sudden outbreak of COVID-19. Moreover, the technological advancements witnessed by the healthcare and diagnostic sector and the emergence of drug-resistant pathogens due to misuse and overuse of antimicrobials also aid in expanding the global market share in the near future. 

According to the World Health Organization, recently identified antibiotic-resistant Mycobacterium tuberculosis strains could turn into the worldwide tuberculosis epidemic. Besides, the annual share of TB with this new strain was predicted to be around 3.4% in 2018, which is another prominent factor favoring the market growth.

On the other hand, inadequate patient education alongside the accessibility to limited diagnostic facilities may obstruct the demand for antimicrobial resistance diagnostics market shortly. But, the budding need for these diagnostics from developing or underdeveloped nations and growing awareness about antimicrobial resistance and its preventive measures are likely to offer lucrative business growth opportunities in upcoming years.

Antibiotic Resistance Diagnostics Market Segmentation

The global antimicrobial resistance diagnostic market is segmented on the basis of pathogen, technology, and region.

By Pathogen

  • Drug Resistant Streptococcus Pneumoniae - DRSP

  • Drug Resistant Campylobacter - DRC

  • Clostridium Difficile - CD

  • Methicillin Resistant Staphylococcus Aureus - MRSA

  • Drug Resistant Neisseria Gonorrhoeae - DRNG

  • Drug Resistant Salmonella - DRNTS

By Technology

  • Microbiology Culture

  • Immunoassay

  • PCR

  • NGS

  • Mass Spectrometry - MS

  • Rapid and Point of Care - Rapid/POC

By Region

  • North America

  • Latin America

  • Europe

  • Africa

  • Middle East

  • Asia Pacific

Antibiotic Resistance Diagnostics Market Key Players

The key participating players of the global antibiotic resistance diagnostics market include Abbott Diagnostics, 1928 Diagnostics, Accelerate Diagnostics, Beckman Coulter Diagnostics, Becton, Dickinson and Company, bioMerieux Diagnostics, Bio-Rad Laboratories, Inc., Curetis N.V. / Curetis GmbH, Enzo Life Sciences, Inc., Eurofins Scientific, Fusion Genomics, GeneFluidics,  Inflammatix, Perkin Elmer, Roche Molecular Diagnostics, Siemens Healthineers, Sysmex, Thermo Fisher Scientific Inc, among others.

R&I Overview on Antibiotic Resistance Diagnostics Market Report

The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give a better opportunity for the customers to put their effort.

A research report on the Antibiotic Resistance Diagnostics market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support the market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth includes (but not restricted to):

New product designs and launches

Current product compliance

Reimbursement

Concerns for use of  Antibiotic Resistance Diagnostics

Advantage of  Antibiotic Resistance Diagnostics

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to make informed decisions.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment where one/two manufacturer(s) dominates the market, it’s product sales, previous growth rates and market expansion plans are considered to generate market share in the global market.


To learn more about this report, request a free sample copy


1. Global Antibiotic Resistance Diagnostics Market Report Overview
1.1. Introduction
1.2. Report Description
1.3. Methodology
2. Global Antibiotic Resistance Diagnostics Market Overview
2.1. Introduction
2.1.1. Introduction
2.1.2. Market Taxonomy
2.2. Executive Summary
2.3. Global Antibiotic Resistance Diagnostics Market Snapshot
2.4. Global Antibiotic Resistance Diagnostics Market Size And Forecast, 2020–2028
2.4.1. Introduction
2.4.2. Market Value Forecast And Annual Growth Rate (AGR) Comparison (2020–2028)
2.5. Global Antibiotic Resistance Diagnostics Market Dynamics
2.5.1. Drivers
2.5.2. Restraints
2.5.3. Opportunity
2.5.4. Trends
2.6. Porter’s Five Forces Model
2.7. SWOT Analysis
2.8. PEST Analysis
2.9. Key Regulations
2.10. Recent Key Developments
2.11. Pricing Analysis
3. Antibiotic Resistance Diagnostics Assessment and Analysis
3.1. Understanding Antimicrobial Resistance 
3.1.1. What is Antimicrobial Resistance (AMR)
3.1.2. Bacteria and Other Microbes
3.1.3. The History of Antibiotics
3.1.4. The Role of Animal Husbandry
3.1.5. The Implications of Horizontal Transfer 
3.1.6. The Changing Road to New Antibiotics & Technologies
3.1.7. The Key Role of Diagnostics in AMR
3.2. Antibiotic Resistance Tests for Emergency Use Technical Overview and Analysis
3.2.1. Time Needed to Get Results
3.2.2. Price of the test
3.2.3. Positioning on the market
3.2.4. Different Techniques Analysis
4. Covid-19 Impact on Antibiotic Resistance Diagnostics Market
5. Global Antibiotic Resistance Diagnostics Market, By Pathogen
5.1. Introduction
5.1.1. Annual Growth Rate Comparison, By Pathogen
5.1.2. BPS Analysis, By Pathogen
5.2. Market Revenue (US$Mn) and Forecast, By Pathogen
5.2.1. Drug Resistant Streptococcus Pneumoniae - DRSP
5.2.2. Drug Resistant Campylobacter - DRC
5.2.3. Clostridium Difficile - CD
5.2.4. Methicillin Resistant Staphylococcus Aureus - MRSA
5.2.5. Drug Resistant Neisseria Gonorrhoeae - DRNG

5.2.6. Drug Resistant Salmonella - DRNTS
5.3. Global Antibiotic Resistance Diagnostics Market Attractiveness Index, By Pathogen
6. Global Antibiotic Resistance Diagnostics Market, By Technology
6.1. Introduction
6.1.1. Annual Growth Rate Comparison, By Technology
6.1.2. BPS Analysis, By Technology
6.2. Market Revenue (US$Mn) and Forecast, By Technology
6.2.1. Microbiology Culture
6.2.2. Immunoassay
6.2.3. PCR
6.2.4. NGS
6.2.5. Mass Spectrometry - MS
6.2.6. Rapid and Point of Care - Rapid/POC
6.3. Global Antibiotic Resistance Diagnostics Market Attractiveness Index, By Technology
7. Global Antibiotic Resistance Diagnostics Market, By Region
7.1. Introduction
7.1.1. Annual Growth Rate Comparison, By Region
7.1.2. BPS Analysis, By Region
7.2. Market Revenue (US$Mn) and Forecast, By Region
7.2.1. North America
7.2.2. Latin America
7.2.3. Europe
7.2.4. Asia Pacific
7.2.5. Middle East
7.2.6. Africa
7.3. Global Antibiotic Resistance Diagnostics Market Attractiveness Index, By Region
8. North America Antibiotic Resistance Diagnostics Market Analysis and Forecast, 2020–2028
8.1. Introduction
8.1.1. Annual Growth Rate Comparison, By Country
8.1.2. BPS Analysis, By Country
8.2. Market Revenue (US$Mn) and Forecast, By Country
8.2.1. U.S. Antibiotic Resistance Diagnostics Market
8.2.2. Canada Antibiotic Resistance Diagnostics Market
8.3. North America Antibiotic Resistance Diagnostics Market, By Pathogen
8.3.1. Drug Resistant Streptococcus Pneumoniae - DRSP
8.3.2. Drug Resistant Campylobacter - DRC
8.3.3. Clostridium Difficile - CD
8.3.4. Methicillin Resistant Staphylococcus Aureus - MRSA
8.3.5. Drug Resistant Neisseria Gonorrhoeae - DRNG
8.3.6. Drug Resistant Salmonella - DRNTS
8.4. North America Antibiotic Resistance Diagnostics Market Revenue (US$Mn) and Forecast, By
Technology
8.4.1. Microbiology Culture
8.4.2. Immunoassay
8.4.3. PCR
8.4.4. NGS
8.4.5. Mass Spectrometry - MS
8.4.6. Rapid and Point of Care - Rapid/POC
8.5. North America Antibiotic Resistance Diagnostics Market Attractiveness Index

8.5.1. By Country
8.5.2. By Pathogen
8.5.3. By Technology
9. Latin America Antibiotic Resistance Diagnostics Market Analysis and Forecast, 2020–2028
9.1. Introduction
9.1.1. Annual Growth Rate Comparison, By Country
9.1.2. BPS Analysis, By Country
9.2. Market (US$Mn) Forecast, By Country
9.2.1. Brazil Antibiotic Resistance Diagnostics Market
9.2.2. Mexico Antibiotic Resistance Diagnostics Market
9.2.3. Rest Of Latin America Antibiotic Resistance Diagnostics Market
9.3. Latin America Antibiotic Resistance Diagnostics Market, By Pathogen
9.3.1. Drug Resistant Streptococcus Pneumoniae - DRSP
9.3.2. Drug Resistant Campylobacter - DRC
9.3.3. Clostridium Difficile - CD
9.3.4. Methicillin Resistant Staphylococcus Aureus - MRSA
9.3.5. Drug Resistant Neisseria Gonorrhoeae - DRNG
9.3.6. Drug Resistant Salmonella - DRNTS
9.4. Latin America Antibiotic Resistance Diagnostics Market Revenue (US$Mn) and Forecast, By
Technology
9.4.1. Microbiology Culture
9.4.2. Immunoassay
9.4.3. PCR
9.4.4. NGS
9.4.5. Mass Spectrometry - MS
9.4.6. Rapid and Point of Care - Rapid/POC
9.5. Latin America Antibiotic Resistance Diagnostics Market Attractiveness Index
9.5.1. By Country
9.5.2. By Pathogen
9.5.3. By Technology
10. Europe Antibiotic Resistance Diagnostics Market Analysis and Forecast, 2020–2028
10.1. Introduction
10.1.1. Annual Growth Rate Comparison, By Country
10.1.2. BPS Analysis, By Country
10.2. Market (US$Mn) Forecast, By Country
10.2.1. U.K. Antibiotic Resistance Diagnostics Market
10.2.2. Germany Antibiotic Resistance Diagnostics Market
10.2.3. Italy Antibiotic Resistance Diagnostics Market
10.2.4. France Antibiotic Resistance Diagnostics Market
10.2.5. Spain Antibiotic Resistance Diagnostics Market
10.2.6. Russia Antibiotic Resistance Diagnostics Market
10.2.7. Poland Antibiotic Resistance Diagnostics Market
10.2.8. BENELUX Antibiotic Resistance Diagnostics Market
10.2.9. NORDIC Antibiotic Resistance Diagnostics Market
10.2.10. Rest Of Europe Antibiotic Resistance Diagnostics Market
10.3. Europe Antibiotic Resistance Diagnostics Market, By Pathogen
10.3.1. Drug Resistant Streptococcus Pneumoniae - DRSP
10.3.2. Drug Resistant Campylobacter - DRC
10.3.3. Clostridium Difficile - CD

10.3.4. Methicillin Resistant Staphylococcus Aureus - MRSA
10.3.5. Drug Resistant Neisseria Gonorrhoeae - DRNG
10.3.6. Drug Resistant Salmonella - DRNTS
10.4. Europe Antibiotic Resistance Diagnostics Market Revenue (US$Mn) and Forecast, By
Technology
10.4.1. Microbiology Culture
10.4.2. Immunoassay
10.4.3. PCR
10.4.4. NGS
10.4.5. Mass Spectrometry - MS
10.4.6. Rapid and Point of Care - Rapid/POC
10.5. Europe Antibiotic Resistance Diagnostics Market Attractiveness Index
10.5.1. By Country
10.5.2. By Pathogen
10.5.3. By Technology
11. Asia Pacific Antibiotic Resistance Diagnostics Market Analysis and Forecast, 2020–2028
11.1. Introduction
11.1.1. Annual Growth Rate Comparison, By Country
11.1.2. BPS Analysis, By Country
11.2. Market (US$Mn) Forecast, By Country
11.2.1. China Antibiotic Resistance Diagnostics Market
11.2.2. India Antibiotic Resistance Diagnostics Market
11.2.3. Japan Antibiotic Resistance Diagnostics Market
11.2.4. Australia and New Zealand Antibiotic Resistance Diagnostics Market
11.2.5. South Korea Antibiotic Resistance Diagnostics Market
11.2.6. Rest of Asia Pacific Antibiotic Resistance Diagnostics Market
11.3. Asia Pacific Antibiotic Resistance Diagnostics Market, By Pathogen
11.3.1. Drug Resistant Streptococcus Pneumoniae - DRSP
11.3.2. Drug Resistant Campylobacter - DRC
11.3.3. Clostridium Difficile - CD
11.3.4. Methicillin Resistant Staphylococcus Aureus - MRSA
11.3.5. Drug Resistant Neisseria Gonorrhoeae - DRNG
11.3.6. Drug Resistant Salmonella - DRNTS
11.4. Asia Pacific Antibiotic Resistance Diagnostics Market Revenue (US$Mn) and Forecast,
By Technology
11.4.1. Microbiology Culture
11.4.2. Immunoassay
11.4.3. PCR
11.4.4. NGS
11.4.5. Mass Spectrometry - MS
11.4.6. Rapid and Point of Care - Rapid/POC
11.5. Asia Pacific Antibiotic Resistance Diagnostics Market Attractiveness Index
11.5.1. By Country
11.5.2. By Pathogen
11.5.3. By Technology
12. Middle East Antibiotic Resistance Diagnostics Market Analysis and Forecast, 2020–2028
12.1. Introduction
12.1.1. Annual Growth Rate Comparison, By Country
12.1.2. BPS Analysis, By Country

12.2. Market (US$Mn) Forecast, By Country
12.2.1. GCC Countries Antibiotic Resistance Diagnostics Market
12.2.2. Israel Antibiotic Resistance Diagnostics Market
12.2.3. Rest Of Middle East Antibiotic Resistance Diagnostics Market
12.3. Middle East Antibiotic Resistance Diagnostics Market, By Pathogen
12.3.1. Drug Resistant Streptococcus Pneumoniae - DRSP
12.3.2. Drug Resistant Campylobacter - DRC
12.3.3. Clostridium Difficile - CD
12.3.4. Methicillin Resistant Staphylococcus Aureus - MRSA
12.3.5. Drug Resistant Neisseria Gonorrhoeae - DRNG
12.3.6. Drug Resistant Salmonella - DRNTS
12.4. Middle East Antibiotic Resistance Diagnostics Market Revenue (US$Mn) and Forecast,
By Technology
12.4.1. Microbiology Culture
12.4.2. Immunoassay
12.4.3. PCR
12.4.4. NGS
12.4.5. Mass Spectrometry - MS
12.4.6. Rapid and Point of Care - Rapid/POC
12.5. Middle East Antibiotic Resistance Diagnostics Market Attractiveness Index
12.5.1. By Country
12.5.2. By Pathogen
12.5.3. By Technology
13. Africa Antibiotic Resistance Diagnostics Market Analysis and Forecast, 2020–2028
13.1. Introduction
13.1.1. Annual Growth Rate Comparison, By Country
13.1.2. BPS Analysis, By Country
13.2. Market (US$Mn) Forecast, By Country
13.2.1. South Africa Countries Antibiotic Resistance Diagnostics Market
13.2.2. Egypt Antibiotic Resistance Diagnostics Market
13.2.3. North Africa Antibiotic Resistance Diagnostics Market
13.2.4. Rest of Africa Antibiotic Resistance Diagnostics Market
13.3. Africa Antibiotic Resistance Diagnostics Market, By Pathogen
13.3.1. Drug Resistant Streptococcus Pneumoniae - DRSP
13.3.2. Drug Resistant Campylobacter - DRC
13.3.3. Clostridium Difficile - CD
13.3.4. Methicillin Resistant Staphylococcus Aureus - MRSA
13.3.5. Drug Resistant Neisseria Gonorrhoeae - DRNG
13.3.6. Drug Resistant Salmonella - DRNTS
13.4. Africa Antibiotic Resistance Diagnostics Market Revenue (US$Mn) and Forecast, By
Technology
13.4.1. Microbiology Culture
13.4.2. Immunoassay
13.4.3. PCR
13.4.4. NGS
13.4.5. Mass Spectrometry - MS
13.4.6. Rapid and Point of Care - Rapid/POC
13.5. Africa Antibiotic Resistance Diagnostics Market Attractiveness Index
13.5.1. By Country

13.5.2. By Pathogen
13.5.3. By Technology
14. Competitive Landscape
14.1. Competition Dashboard
14.2. Company Share Analysis
14.2.1. Market Analysis by Tier of Companies
14.2.2. Market Share Analysis of Top Players
14.2.3. Market Presence Analysis
14.2.4. Regional Footprint of Players
14.2.5. Product Footprint by Players
14.2.6. Channel Footprint by Players
14.3. Company Profiles
14.3.1. Abbott Diagnostics
14.3.1.1. Company Overview
14.3.1.2. Financial Overview
14.3.1.3. Key Developments
14.3.1.4. Strategies
14.3.1.5. Product Analysis
14.3.2. 1928 Diagnostics
14.3.3. Accelerate Diagnostics
14.3.4. Beckman Coulter Diagnostics
14.3.5. Becton, Dickinson and Company
14.3.6. bioMerieux Diagnostics
14.3.7. Bio-Rad Laboratories, Inc.
14.3.8. Curetis N.V. / Curetis GmbH
14.3.9. Enzo Life Sciences, Inc.
14.3.10. Eurofins Scientific
14.3.11. Fusion Genomics
14.3.12. GeneFluidics
14.3.13. Inflammatix
14.3.14. Perkin Elmer
14.3.15. Roche Molecular Diagnostics
14.3.16. Siemens Healthineers
14.3.17. Sysmex
14.3.18. Thermo Fisher Scientific Inc
15. Acronyms

Select License Type

Frequently Asked Questions

Antibiotic resistance composes a global strain and is one of the crucial threats to public health. Even though the advent of resistant microorganisms is a natural occurrence, the unseemly or overuse of antibiotics is likely to have a significant impact on resistance phylogeny.

the growing occurrence of infectious diseases coupled with the sudden outbreak of COVID-19

The global antimicrobial resistance diagnostic market is segmented on the basis of pathogen, technology, and region.

The key participating players of the global antibiotic resistance diagnostics market include Abbott Diagnostics, 1928 Diagnostics, Accelerate Diagnostics, Beckman Coulter Diagnostics, Becton, Dickinson and Company, bioMerieux Diagnostics, Bio-Rad Laboratories, Inc., Curetis N.V. / Curetis GmbH, Enzo Life Sciences, Inc., Eurofins Scientific, Fusion Genomics, GeneFluidics, Inflammatix, Perkin Elmer, Roche Molecular Diagnostics, Siemens Healthineers, Sysmex, Thermo Fisher Scientific Inc, among others